文献速递免疫规划传染病防控与疫情报告

日本婴儿期四剂百日咳疫苗效力在小学年龄下降:一项检测阴性病例对照研究

Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.
PubMed 文献 · Vaccine · 2020-11-20

结果显示四剂疫苗总体效力70%,6岁以下儿童达90%(边缘显著性),但学龄儿童仅8%无保护提示,且随第四剂接种后时间延长发病风险显著增加。

要点

  • 婴儿期四剂百日咳疫苗总体效力70%,6岁以下儿童达90%。
  • 学龄儿童疫苗效力仅8%,未见保护作用。
  • 第四剂接种后时间越长,百日咳发病风险显著增加。

核心结论

  • 婴儿期四剂百日咳疫苗的效力随第四剂接种后时间延长而下降。
  • 该四剂方案不能保护学龄儿童免受百日咳侵袭。

研究设计与样本

  • 共招募187名受试者(120例病例和67例对照),获得145份问卷回复(95例病例和50例对照)。
  • 通过父母问卷结合免疫记录收集接种史,采用逻辑回归计算比值比(OR)和95%置信区间。

主要发现

  • 与未接种者相比,四剂疫苗在所有受试者中的效力为70%。
  • 6岁以下受试者四剂疫苗效力达90%,但仅具边缘显著性。
  • 学龄期受试者疫苗效力为8%,未提示保护作用。
  • 接种四剂者中,距第四剂时间越长,发生百日咳的OR显著增加(与<4.5年相比,6.0-8.2年OR=5.74;≥8.3年OR=3.88;趋势P<0.01)。

临床怎么用

  • 应关注学龄儿童百日咳风险,婴儿期四剂方案可能不足以提供持续保护。
  • 对距第四剂接种时间较长的儿童,需考虑加强免疫或早期诊断。

局限性

  • 部分招募对象未获得问卷回复,可能引入选择偏倚。
  • 疫苗接种史依赖父母问卷和免疫记录,可能存在回忆偏倚。
  • 研究为单国设计,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Japanese national immunization program recommends that children receive 4 doses of acellular pertussis vaccine between 3 months and 2 years of age. Nevertheless, the number of pertussis cases is increasing in elementary school children aged 6-12 years. Therefore, a test-negative case-control study was conducted to assess the effectiveness of the pertussis vaccine program. METHODS: Subjects included children aged ≥3 months who visited a collaborating hospital due to pertussis-specific cough between October 2017 and November 2019. All subjects underwent diagnostic tests for pertussis, and those diagnosed as positive were regarded as cases. Subjects diagnosed as pertussis-negative were classified as controls. Vaccination history was collected using a questionnaire administered to parents with reference to immunization records. Logistic regression models were employed to calculate the odds ratio (OR) and 95% confidence interval for laboratory-confirmed pertussis. RESULTS: Of 187 recruited subjects (120 cases and 67 controls), questionnaire responses were obtained for 145 subjects (95 cases and 50 controls). Compared with unvaccinated subjects, the vaccine effectiveness (VE) of 4 doses was 70% among all subjects and reached to 90% with marginal significance among subjects under 6 years of age. However, among school-aged subjects, the VE was not suggestive of protection against pertussis (VE: 8%). For vaccinees given 4 doses, the OR for developing pertussis increased significantly with longer duration since the fourth dose (compared with <4.5 years, OR of 6.0-8.2 years = 5.74; OR of ≥8.3 years = 3.88; P for trend by duration < 0.01). CONCLUSION: Effectiveness of administering 4 doses of pertussis vaccine during infancy decreases with time passed since the fourth dose. This regimen does not protect school-aged children against pertussis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ohfuji S, Okada K, Mouri Y, et al. Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan. Vaccine. 2020. PMID: 33229109. doi:10.1016/j.vaccine.2020.11.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。